Iobenguane
From Wikipedia, the free encyclopedia
 |
|
|
Iobenguane
|
|
| Systematic (IUPAC) name | |
| 1-(3-iodobenzyl)guanidine | |
| Identifiers | |
| CAS number | |
| ATC code | V09 V09IX02 V10XA02 |
| PubChem | |
| Chemical data | |
| Formula | C8H10IN3 |
| Mol. mass | 275.09 g/mol |
| Synonyms | meta-iodobenzylguanidine mIBG, MIBG |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | Intravenous |
Iobenguane, also known as metaiodobenzylguanidine or mIBG, is a radiopharmaceutical.[1] It is a radiolabeled molecule similar to norepinephrine.
The isotope of iodine used can be Iodine-123 or Iodine-131.
It can be used to identify the location of certain types of tumors.[2]
[edit] References
- ^ Iobenguane I 131 Sulfate (Intravenous Route) - MayoClinic.com. Retrieved on 2007-12-15.
- ^ Scarsbrook AF, Ganeshan A, Statham J, et al (2007). "Anatomic and functional imaging of metastatic carcinoid tumors". Radiographics 27 (2): 455–77. doi:. PMID 17374863.
|
||||||||
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
